COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,281 Articles (22,759 medRxiv, 8,522 bioRxiv)

Most recent first Previous |  Page 1429: Articles 14281-14290  | Next

Diet quality and risk and severity of COVID-19: a prospective cohort study
Merino, J., Joshi, A. D., Nguyen, L., Leeming, E., Drew, D. A., Gibson, R., Graham, M. S., Mazidi, M., Lo, C.-H., Capdevila, J., Murray, B., hu, c., Selvachandran, S., Kwon, S., MA, W., Menni, C., Hammers, A., Bhupathiraju, S., Sharma, S., Sudre, C., Astley, C. M., Willett, W., Chavarro, J., Ourselin, S., Steves, C., Wolf, J., Franks, P. W., Spector, T., Berry, S., Chan, A. T.
10.1101/2021.06.24.21259283 — Posted: 2021-06-25 Discussion: Onsite
Averting an outbreak of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a university residence hall through wastewater surveillance
Corchis-Scott, R., Geng, Q., Seth, R., Ray, R., Beg, M., Biswas, N., Charron, L., Drouillard, K. G., D'Souza, R., Heath, D. D., Houser, C., Lawal, F., McGinlay, J., Menard, S. L., Porter, L. A., Rawlings, D., Tong, Y., Scholl, M. L., Siu, K. W. M., Weisener, C. G., Wilhelm, S. W., McKay, R. M. L.
10.1101/2021.06.23.21259176 — Posted: 2021-06-25
Pre-existing anxiety, depression, and neurological disability are associated with long COVID: A prospective and longitudinal cohort study of the United Kingdom Multiple Sclerosis Register
Garjani, A., Middleton, R. M., Nicholas, R., Evangelou, N.
10.1101/2021.06.25.21259256 — Posted: 2021-06-25
Microsimulation based quantitative analysis of COVID-19 management strategies
Reguly, I. Z., Csercsik, D., Juhasz, J., Tornai, K., Bujtar, Z., Horvath, G., Keomley-Horvath, B., Kos, T., Cserey, G., Ivan, K., Pongor, S., Szederkenyi, G., Rost, G., Csikasz-Nagy, A.
10.1101/2021.06.20.21259214 — Posted: 2021-06-25
Covid-19 Incidence And Mortality By Age Strata And Comorbidities In Mexico City: A Focus In The Pediatric Population
CASTILLA PEON, M. F., Gonzalez-Garcia, N., Solorzano-Santos, F., Jimenez Juarez, R., Martinez Bustamante, M. E., Minero Hibert, M. A., Garduno Espinosa, J.
10.1101/2021.06.21.21259282 — Posted: 2021-06-25
MONITORING SARS-COV-2 TRANSMISSION AND PREVALENCE IN POPULATIONS UNDER REPEATED TESTING
Wascher, M., Schnell, P. M., Khudabukhsh, W. R., Quam, M., Tien, J. H., Rempala, G. A.
10.1101/2021.06.22.21259342 — Posted: 2021-06-25 Discussion: Onsite
Acceptability, usability and performance of lateral flow immunoassay tests for SARS-CoV-2 antibodies: REACT-2 study of self-testing in non-healthcare key workers
Davies, B., Araghi, M., Moshe, M., Gao, H., Bennet, K., Jenkins, J., Atchison, C., Darzi, A., Ashby, D., Riley, S., Barclay, W., Elliott, P., Ward, H., Cooke, G.
10.1101/2021.06.21.21259254 — Posted: 2021-06-25
Can Auxiliary Indicators Improve COVID-19 Forecasting and Hotspot Prediction?
McDonald, D. J., Bien, J., Green, A., Hu, A. J., DeFries, N., Hyun, S., Oliveira, N. L., Sharpnack, J., Tang, J., Tibshirani, R., Ventura, V., Wasserman, L., Tibshirani, R. J.
10.1101/2021.06.22.21259346 — Posted: 2021-06-25
Report on Three Round COVID-19 Risk Blind Tests by Screening Eye-region Manifestations
Fu, Y., Zhao, L., Zheng, H., Sun, Q., Yang, L., Li, H., Xie, J., Sue, X., Li, F., Li, Y., Yang, W., Pei, Y., Wang, J., Wu, X., Zheng, Y., Tian, H., Gu, M.
10.1101/2021.06.23.21258626 — Posted: 2021-06-25
Integrating PCR-free amplification and synergistic sensing for ultrasensitive and rapid CRISPR/Cas12a-based SARS-CoV-2 antigen detection
Zhao, X., Wang, Z., Yang, B., Li, Z., Tong, Y., Bi, Y., Li, Z., Xia, X., Chen, X., Wang, W., Tan, G.-Y., Zhang, L.
10.1101/2021.06.17.21258275 — Posted: 2021-06-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).